Study
EORTC-1726-QLG
Evaluating the use of the E-PRO measures for improving inter-rater reliability of CTCAE ratings
Trial Status
Recruiting
Dates
Data management at EORTC
None
Design
QoL Non Mod Dev.
Not randomized / N.A.
Not randomized / N.A.
Treatment
None
Study Staff
- Bernhard Holzner (Study Coordinator), A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck
- Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
- Corneel Coens (Statistician), EORTC Headquarters, Brussels
- Lisa Wintner (Study Co-Coordinator), A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck
Type of cancer
- Lung
- Melanoma
- Acute Myelogenous Leukemia
- Hodgkins Disease
- Testicular
- Prostate
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Myelodysplastic Syndroms
- Breast
- Non Hodgkins Lymphoma
- Brain
- Bladder
- Kidney
- Colon
- Rectal
- Gastric
- Esophageal
- Pancreatic
- Liver
- Ovarian
- Endometrium
- Cervical
- Vulvar
- Osteosarcoma
- Thyroid
- Soft Tissue and Bone Sarcoma
- Fallopian Tube
- Neuroendocrine
- Biliary Tract
- Head and Neck
- Refractory Lymphoid Neoplasms
- Mesothelioma
- Uterine
- Multiple Myeloma
- Uveal Melanoma
- Solid Tumors, Unspecified
- Penile
- Primary Cutaneous Lymphomas
- Colorectal
- Vaginal
- Anal
- Thymoma
Participating groups
- EORTC Quality of Life Group